AI for Neurology market is valued at $927.5 Mn in 2026, growing at 24.6% CAGR through 2035. Covers key players, segments, and regional forecasts.

The AI For Neurology Market is experiencing strong growth driven by the increasing prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and stroke. Rising demand for early diagnosis, precision treatment, and improved patient outcomes is significantly accelerating the adoption of AI-powered neurological solutions. Advanced machine learning algorithms and deep learning models are enhancing brain imaging analysis, predictive diagnostics, and clinical decision support systems in neurology.

Growing integration of AI in healthcare infrastructure, along with expanding digital health ecosystems, is further boosting market development. The use of AI in neuroimaging, cognitive assessment, and real-time monitoring is transforming traditional neurological care practices. Increasing investments in healthcare AI startups and research initiatives are also supporting innovation in this space. North America leads the market due to advanced healthcare technology adoption, while Asia-Pacific is expected to show rapid growth. The market is poised for sustained expansion as AI continues to reshape neurological diagnostics and treatment pathways.

Europe AI for Neurology Market

The Europe AI for Neurology Market is estimated to be valued at USD 222.6 million in 2026, witnessing growth at a CAGR of 25.3%, during the forecast period.

The market of AI for neurology is mature in Europe, and it has a strong effect on the regulatory specifications and the regional policies including the EU AI Act, the European Health Data Space (EHDS), and national digital health programs (e.g., the Health Data Hub in France and the Digital Healthcare Act in Germany). Another area that countries are working towards is smart neurology modularization in order to align clinical and research workload demands and interoperability of cross-border brain health data supply chains. It is driven by advanced technologies, such as real-time brain imaging analysis engines and high-reliability cognitive decline scoring systems with an inbuilt predictive algorithm on the development of Parkinson. Adoption is facilitated by the use of public-private partnerships and harmonization of AI neurology standards. Technologies like real-time computational workload balancing and smart contract-based data sharing are commonly practiced as research-centric programs, and Europe is a frontrunner in terms of the digital transformation of safe and efficient AI neurology care.

Japan AI for Neurology Market

The Japan AI for Neurology Market is projected to be valued at USD 57.0 million in 2026, progressing at a CAGR of 26.8%, during the period spanning from 2026 to 2035.

Japan boasts a mature AI for neurology market supported by high-performance neuroimaging systems, diagnostic EEG integration technology, and a wide network of robotic neurorehabilitation AI innovations. Automation, precision, and clinical integrity are the priorities in the country and are achieved by predictive neurological progression models and intelligent patient management systems for chronic neurological conditions. Growth is stimulated by government actions under the Society 5.0 initiative and constant investment in digital health infrastructure. The high volume of aging population care, chronic disease management for Parkinson’s and Alzheimer’s, and neurology clinic automation requires efficient AI for real-time evidence-based inference. The difficulties are high validation costs for new neurology AI architectures and integration with legacy diagnostic imaging systems, yet the prospects are in exporting developed AI neurology technologies to Asian and Pacific markets.